NCT03363802Unknown不适用
Assessment of Pubertal Growth Spurt in Growing Egyptian Females Using Modified Middle Phalanx of The Middle Finger Stages and Its Correlation With Development Stage of Mandibular Second Molar in Al Sharkia Governorate
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 1,600
- 试验地点
- 1
- 主要终点
- Assessment of the time of pubertal growth spurt in growing Egyptian
研究概览
简要总结
Assessment of Pubertal Growth Spurt in Growing Egyptian Females Using Modified Middle Phalanx of The Middle Finger Stages and Its Correlation With Development Stage of Mandibular Second Molar
详细描述
The sample will be selected randomly from different schools in the government.
- Digital periapical radiograph for the middle finger for each participants will be taken using Digital x-ray portable machine.
- Radiographical images will be stored in a digital sensor to be transferred to computer then we asses growth spurt in girls and correlate it with devlopemt stage of mandibular second molar
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 9 Years 至 14 Years（Child）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Egyptian citizen
排除标准
- •Systemic disease and syndromes
- •Severe crowding
结局指标
主要结局
Assessment of the time of pubertal growth spurt in growing Egyptian
时间窗: 3month
Taking xray of middle phalynx finger and then asses age of growth spurt through stages of middle phalynx finger
次要结局
- females. Assessment the correlation between the modified middle phalanx of the middle finger and development stage of mandibular second molar(3month)
研究者
Mahmoud Magdy
Principal Investigator,Ms candidate
Cairo University
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Gingival Crevicular Fluid Alkaline Phosphatase as Skeletal Growth IndicatorGrowth IndictaorNCT04452071Cairo University92
已完成
4 期
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic DrugsNL-OMON34837Janssen-Cilag40
进行中（未招募）
不适用
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugsong-term safety data in children and adolescents will be collected from a population of patients with a diagnosis of schizophrenia, bipolar mania, autistic disorder or conduct and other disruptive disorders undergoing routine standard of care treatment.MedDRA version: 12.1Level: LLTClassification code 10039626Term: SchizophreniaMedDRA version: 12.1Level: HLGTClassification code 10026753Term: Manic and bipolar mood disorders and disturbancesMedDRA version: 12.1Level: LLTClassification code 10003805Term: AutismEUCTR2009-012003-26-GRJanssen-Cilag International, NV350
进行中（未招募）
1 期
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugsong-term safety data in children and adolescents will be collected from a population of patients with a diagnosis of schizophrenia, bipolar mania, autistic disorder or conduct and other disruptive disorders undergoing routine standard of care treatment.MedDRA version: 12.1Level: LLTClassification code 10039626Term: SchizophreniaMedDRA version: 12.1Level: HLGTClassification code 10026753Term: Manic and bipolar mood disorders and disturbancesMedDRA version: 12.1Level: LLTClassification code 10003805Term: AutismEUCTR2009-012003-26-BEJanssen-Cilag International, NV350
进行中（未招募）
不适用
Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugsong-term safety data in children and adolescents will be collected from a population of patients with a diagnosis of schizophrenia, bipolar mania, autistic disorder or conduct and other disruptive disorders undergoing routine standard of care treatment.MedDRA version: 12.1Level: LLTClassification code 10039626Term: SchizophreniaMedDRA version: 12.1Level: HLGTClassification code 10026753Term: Manic and bipolar mood disorders and disturbancesMedDRA version: 12.1Level: LLTClassification code 10003805Term: AutismEUCTR2009-012003-26-NLJanssen-Cilag International, NV350